J. Stuart Ferriss

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro et al. · Journal of Clinical Oncology · 2019 · 461 citations · Full text

When ‘never-events’ occur despite adherence to clinical guidelines: The case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes

Linda Duska, Leslie A. Garrett, Melissa Henretta et al. · Gynecologic Oncology · 2009 · 129 citations

Thrombosis, ‘ Never-events, Venous Disease +12

Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance

J. Stuart Ferriss, Youngchul Kim, Linda Duska et al. · PLoS ONE · 2012 · 115 citations · Full text

Adjuvant Chemotherapy, Gynecology, Pathology +18

Cancer in Obese Women: Potential Protective Impact of Bariatric Surgery

Gwyneth M. McCawley, J. Stuart Ferriss, Dyanna L. Geffel et al. · Journal of the American College of Surgeons · 2009 · 94 citations

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Advanced Ovarian Cancer, Medicine, Pharmacology +9